Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pioneering Technology Leads to First 3-Tesla, Cryogen-Free MRI Benchtop Scanner

By LabMedica International staff writers
Posted on 06 Mar 2013
Applying technological advances related to supercooling has enabled the development of a superior and more convenient 3-Tesla MRI scanner for biological and medical research laboratories.

The new “3T MRI” benchtop scanner, developed by MR Solutions (Guildford, UK), provides superior soft tissue contrast and molecular imaging capability as well as a breakthrough design that enables it to be conveniently fitted into an existing laboratory. More...


The scanner includes two major advances. First, the usual MRI liquid helium cooling system has been replaced by using a revolutionary magnet design incorporating new superconducting wire. Through a technology solution pioneered by MR Solutions and its magnet partner, this enables the use of a standard low-temperature cryocooler to cool the magnet to the 4 Kelvin required to achieve superconductivity. Second, the 3T MRI scanner does not require that it be isolated in a “Faraday cage” as its stray magnetic field is only a few centimetres and will not interfere with other equipment in a laboratory. The elimination of the helium cooling system has allowed an optimal installation of an additional solenoid to counter the stray magnetic field. These advances have also dramatically reduced the cost of this powerful scanner to make it highly competitive.

Professor Van der Linden from Bio Imaging Laboratory of the University of Antwerp commented, “This new scanner is a breakthrough and will provide us with the extra scanning power we need within our existing facilities. We can just wheel it in without knocking down any walls and without having to install a costly helium system and the safety system that goes with it. And as its stray magnetic field is so small, we can put other sensitive laboratory equipment and scanners close by for much better work flow.”

Related Links:
MR Solutions



Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.